Lumify® is Different
What’s the Secret?
Alright, we’ll share.
To be sure this product is right for you, always read and follow the label. Simulation reflects average clinical trial results.
LUMIFY® formulation was developed by eye doctors.
Eye doctors figured out that low-dose brimonidine tartrate could help relieve redness with a lower risk of certain side effects when used as directed. That’s how low-dose brimonidine became the star ingredient in LUMIFY®.
*Low-dose OTC brimonidine
So, how does low-dose brimonidine work?
Low-dose brimonidine constricts the venules, which helps to relieve redness without limiting the flow of oxygen. The results? Whiter, brighter looking eyes that last up to 6-8 hours – with a low risk of rebound redness when used as directed.1
What makes eye doctors choose LUMIFY®?
Doctors like LUMIFY® because of the reduced risk of rebound redness. And it’s clinically proven to be safe, effective, and not lose efficacy over time when used as directed. No wonder it’s the #1 eye doctor recommended redness reliever eye drop.†
†IQVIA ProVoice 2021, North America
So what we’re saying is…
Eye doctor developed formulation
Clinically tested
Reduced risk of rebound redness when used as directed
#1 Eye Doctor Recommended redness reliever eye drop*
1See LUMIFY® Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php).*IQVIA ProVoice 2021, North America
Real people. Real results.
See why LUMIFY® has a 95% satisfaction rating.**
And the best part? It’s from the eye care experts at BAUSCH + LOMB
**Source: according to an In-Home Use Test survey conducted in March 2018 (n=301)